Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

587 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Technical report: liquid overlay technique allows the generation of homogeneous osteosarcoma, glioblastoma, lung and prostate adenocarcinoma spheroids that can be used for drug cytotoxicity measurements.
Jubelin C, Muñoz-Garcia J, Cochonneau D, Ollivier E, Vallette F, Heymann MF, Oliver L, Heymann D. Jubelin C, et al. Among authors: heymann d, heymann mf. Front Bioeng Biotechnol. 2023 Oct 6;11:1260049. doi: 10.3389/fbioe.2023.1260049. eCollection 2023. Front Bioeng Biotechnol. 2023. PMID: 37869710 Free PMC article.
Roles of inflammatory cell infiltrate in periprosthetic osteolysis.
Panez-Toro I, Heymann D, Gouin F, Amiaud J, Heymann MF, Córdova LA. Panez-Toro I, et al. Among authors: heymann d, heymann mf. Front Immunol. 2023 Dec 1;14:1310262. doi: 10.3389/fimmu.2023.1310262. eCollection 2023. Front Immunol. 2023. PMID: 38106424 Free PMC article. Review.
IL-34 Exerts Anti-Inflammatory Activities on Keratinocytes and Is Downregulated in Psoriatic-Inflamed Skin.
Croquette M, Faugeroux A, Fonlupt C, Godet J, Frouin É, Garcia M, Bernard FX, Cordier-Dirikoc S, Pedretti N, Larid G, Favot L, Roblot P, Boutin D, Hainaut-Wierzbicka E, Heymann D, Lecron JC, Morel F, Jégou JF. Croquette M, et al. Among authors: heymann d. J Invest Dermatol. 2023 Dec;143(12):2521-2524.e5. doi: 10.1016/j.jid.2023.05.023. Epub 2023 Jun 12. J Invest Dermatol. 2023. PMID: 37315881 Free article. No abstract available.
A personalized medicine approach identifies enasidenib as an efficient treatment for IDH2 mutant chondrosarcoma.
Rey V, Tornín J, Alba-Linares JJ, Robledo C, Murillo D, Rodríguez A, Gallego B, Huergo C, Viera C, Braña A, Astudillo A, Heymann D, Szuhai K, Bovée JVMG, Fernández AF, Fraga MF, Alonso J, Rodríguez R. Rey V, et al. Among authors: heymann d. EBioMedicine. 2024 Apr;102:105090. doi: 10.1016/j.ebiom.2024.105090. Epub 2024 Mar 27. EBioMedicine. 2024. PMID: 38547578 Free PMC article.
587 results